SUMATRIPTAN (SUMATRIPTAN) — FDA Approval ANDA213465 (PADAGIS ISRAEL)
SUMATRIPTAN (SUMATRIPTAN) — FDA Approval ANDA213465 (PADAGIS ISRAEL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUMATRIPTAN; Active ingredients: SUMATRIPTAN; Application number: ANDA213465.
| Brand name | SUMATRIPTAN |
|---|---|
| Active ingredients | SUMATRIPTAN |
| Application number | ANDA213465 |
| Sponsor | PADAGIS ISRAEL |
| Dosage form | SPRAY |
| Route | NASAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20200921 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →